IL10 and cancer: Considering the ability of a broad-MMP inhibitor to decrease cancer cell invasion and cancer cell-induced angiogenesis, we hypothesized that the distinct ability of LPS- and IL-10-stimulated macrophages in inducing these cancer cell activities could be associated to proteolytic differences.